Stocks and Investing Stocks and Investing
Wed, July 3, 2024
Tue, July 2, 2024

Vijay Kumar Maintained (ABT) at Buy with Decreased Target to $120 on, Jul 2nd, 2024


Published on 2024-10-28 12:13:31 - WOPRAI, Vijay Kumar
  Print publication without navigation


Vijay Kumar of Evercore ISI Group, Maintained "Abbott Laboratories" (ABT) at Buy with Decreased Target from $125 to $120 on, Jul 2nd, 2024.

Vijay has made no other calls on ABT in the last 4 months.



There are 5 other peers that have a rating on ABT. Out of the 5 peers that are also analyzing ABT, 0 agree with Vijay's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Vijay


  • Shagun Singh of "RBC Capital" Reiterated at Buy and Held Target at $125 on, Tuesday, June 4th, 2024
  • David Roman of "Goldman Sachs" Initiated at Strong Buy and Held Target at $121 on, Thursday, May 30th, 2024
  • Joanna Wiensch of "Citigroup" Maintained at Strong Buy with Decreased Target to $119 on, Wednesday, May 22nd, 2024
  • Matt Miksic of "Barclays" Maintained at Buy with Decreased Target to $140 on, Monday, April 22nd, 2024
  • Joanne Wuensch of "Citigroup" Maintained at Strong Buy with Increased Target to $128 on, Wednesday, April 3rd, 2024

Contributing Sources
    D885FD0B-4D59-419D-81DE-3DF4BF5AB503
  • support@woprai.com